Une société de biopharmacie du Top 20 utilise Veeva Development Cloud pour accélérer la mise à disposition de traitements pour des maladies actuellement incurables. INGELHEIM, Allemagne et BARCELONE, Espagne, 11 mars 2025 /PRNewswire/ — Boehringer Ingelheim et Veeva Systems (NYSE : VEEV)…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.